Home›Stock Screener›Panacea Biotec›Quarterly Results

Panacea Biotec Quarterly Results

Latest Quarter Net Profit
₹-1 Cr
QMar 2026
Quarterly Results

Panacea Biotec quarterly results. In Mar 2026, Panacea Biotec (PANACEABIO) reported revenue ₹172 Cr and net profit ₹-1 Cr — revenue +1.8% YoY. Check PANACEABIO company valuation to track the company's total market size over time.

PANACEABIO Quarterly Results — Revenue, Profit & EPS Highlights

Panacea Biotec latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review PANACEABIO P/E ratio to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹172 Cr in Mar 2026 (-16.9% vs Jun 2026, +1.8% vs Mar 2025)
  • Net Profit of ₹-1 Cr in Mar 2026 (-150.0% vs Jun 2026, +50.0% vs Mar 2025)
  • EBITDA of ₹8 Cr in Mar 2026 (-38.5% vs Jun 2026)
  • Operating Margin of 2.0% in Mar 2026 (-1.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.08 in Mar 2026 (-78.9% vs Jun 2026)

Panacea Biotec Quarterly Results — Revenue, EBITDA, Net Profit & EPS

PANACEABIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 172 207 150 169 184 -16.9% 1.8%
Net Profit (₹ Cr) -1 2 -14 -2 4 - -
EBITDA (₹ Cr) 8 13 -9 9 16 - -
EPS (₹) 0.08 0.38 -2.27 -0.31 0.66 - -
Operating Margin (%) 2.0% 3.0% -13.0% -20.0% -1.0% - -

PANACEABIO Share Price Trend — 1-Year Movement Across Quarterly Results

Panacea Biotec 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Panacea Biotec share price chart.

Profitability Ratios

Profit Margin -0.6%
EBITDA Margin 4.7%
Operating Margin 2.0%
ROE (Annual) -0.5%

Balance Sheet Highlights

Total Assets ₹1,262 Cr
Total Equity ₹829 Cr
Current Assets ₹513 Cr
Current Liabilities ₹85 Cr

Cash Flow Analysis

Operating Cash Flow ₹17 Cr
Investing Cash Flow ₹-41 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹-25 Cr

Current Market Data

Current Price ₹350.25
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 169
Sept 2025 150
Jun 2026 207
Mar 2026 172

Net Profit Trend (₹ Cr)

Mar 2025 -2
Sept 2025 -14
Jun 2026 2
Mar 2026 -1

Operating Margin Trend (%)

Mar 2025 -20.0%
Sept 2025 -13.0%
Jun 2026 3.0%
Mar 2026 2.0%

PANACEABIO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Panacea Biotec latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Laurus Labs
Mar 2026 		₹109,629.35 Cr 1971.4 1,823 282 -10.5% - 15.5% 381.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores